Intelligent Fingerprinting, the company behind the first portable fingerprint-based drug testing system, has launched a new drug screening test designed to meet the needs of drug rehabilitation organisations. The test is fingerprint-based, taking less than a minute to collect a fingerprint sweat samples onto the small drug screening cartridge and just ten minutes to screen for the opioid substitution drugs methadone and buprenorphine.
The new drug treatment screening cartridge also tests for benzodiazepines as well as opiates, significantly enhancing the range of Intelligent Fingerprinting products available to drug treatment service providers.
The simple, dignified and non-invasive nature of fingerprint-based drug testing makes it ideally suited to the needs of drug treatment services. The portable system is designed for use in various situations, including non-clinical settings, making it easier for drug treatment programme staff to set up screening sessions, collect samples, administer tests and obtain results quickly. This allows test outcomes to be discussed with clients during the same session.
